Beach Crasher and Cataract Kush: the same THC range, two different leading terpenes

• Profile. Beach Crasher leads with caryophyllene, Cataract Kush leads with myrcene.
• Availability. Both are supplied by S-LAB, Synoptis Pharma, Tilray, so one order can cover both.
• Origin. The lineage of both is established.
• What this table does not say. It does not include the declared content as a single number or price. Which strain is suitable for whom is determined by the attending physician, not by the feature comparison.

What do these two strains really differ in?

In the leading terpene and lineage, not potency. The databases provide the same THC content range for both cultivars and the same trio of producers, so the number on the label does not separate them at all. They are separated by composition: Beach Crasher is led by caryophyllene, while Cataract Kush is led by myrcene.

The range of 16.2-24.2% appears in this comparison fifteen times out of eighty-five cultivars, so it does not stand out by itself. It was created by combining several separate registry entries with two levels of declared potency, one for each producer and level. The pharmacy issues such a single entry, not a strain understood as a name, and its packaging carries the declared value.

The second difference lies in the description of genetics and is visible at first glance. All pharmacy entries describe Cataract Kush the same way, as an indica strain. Beach Crasher has two descriptions at once: one database calls it a hybrid, the other a hybrid with indica dominance. Such a discrepancy is not a transcription error, but a trace that the genetic label comes from a catalog description, not from a measurement made on a series.

What connects them?

The same trio of producers, the same potency range, and six common terpenes. The entire profile of Cataract Kush fits within the profile of Beach Crasher: no terpene listed for one strain is absent from the other, and Beach Crasher adds two more entries to this set.

On the lineage side, a common point also exists, but it requires caution. Cataract Kush comes from a cross of LA Confidential with OG Kush, and the breeder records it that way. The second parent of Beach Crasher is TK Bx1, which is the first backcross of the Triangle Kush line. The Triangle Kush itself is described by some studies as a Florida phenotype of OG Kush, while the seed base derives it from random pollination of Emerald Triangle plants with Hindu Kush pollen. Therefore, the common ancestor is a hypothesis in the industry, not a record from the card.

OG Kush behaves in this comparison like a family name, not like a single plant: four cultivars have it directly listed as a parent, two others have its branch. Therefore, the kinship field is empty for both strains, and this is a correct result, not a gap to be filled. The name component proves even less: the word kush carries ten names here, and for five of them, the lineage remains unestablished.

Which of the two terpene profiles is better documented?

Neither is well documented, but they differ in the type of absence. The Beach Crasher profile is described by two sources, and these sources differ in composition: bisabolol, limonene, and linalool are mentioned by only one of them. The Cataract Kush profile is described by one source, so there is nothing to compare it with.

The discrepancy does not end with the list of names. The same database provides two different sets for Beach Crasher depending on the registry entry, and the percentages sum up to 86 in one of them, to exactly one hundred in the other, while for Cataract Kush, it sums to 94. Since one sum closes to one hundred and the other does not reach it, the denominator is unknown and different for each entry. Hence the decision to present the composition as a list, without a number next to the name.

The practical effect is that the comparison of the profiles of these two strains compares two catalog descriptions, not two analyses. For Beach Crasher, the choice of source even changes what accompanies the leading terpene: one entry has nerolidol in its description, while another does not mention it at all. For Cataract Kush, there is no choice, as there is one description, and the lack of contradiction is not the same as confirmation.

What has been shown for caryophyllene, the leading terpene of Beach Crasher?

Two studies on mice, both about pain and inflammation, none about the strain itself. The first showed that caryophyllene binds to the CB2 receptor and that without this receptor, its anti-inflammatory effect disappears. The second described analgesic effects after oral administration in rodents.

Gertsch and colleagues described the first in 2008 (PMID:18574142): the binding was selective, and the paw swelling subsided in normal mice but not in those lacking the CB2 receptor. The model included a mouse and binding measurement in vitro on human cells, so it speaks about the mechanism, not about patients. Klauke and colleagues in 2014 (PMID:24210682) worked on a mouse model and described a reduction in the late, inflammatory phase of pain after oral administration, with chronic administration not leading to tolerance.

Both of these studies share a common boundary. In neither of the two studies was caryophyllene tested on humans or in inhaled form from flower; both studies concern oral or systemic administration in pain and inflammation models, not sleep or mood.

It is worth comparing this record with what the sales card says about the strain. For both Beach Crasher and Cataract Kush, the same database enters one word in the possible effects column, relaxing. This is a catalog label and user report, not a measurement result, and does not separate these two entries in any way.

What has been shown for myrcene, the leading terpene of Cataract Kush?

Three studies on mice, and their results do not form a single answer. Intraperitoneal administration prolonged sleep induced by pentobarbital, but it performed poorly in the anxiety test. Inhalation produced an anxiolytic effect only in females. The third study concerned pain and indicated a mechanism outside the cannabinoid system.

De Vale’s team described in 2002 (PMID:12587690) a decrease in the motor activity of mice and more than double the prolongation of sleep at the higher of the doses studied, while also fewer entries into the open arms of the maze, which the authors called a weak anxiogenic effect. Rao’s team in 1990 (PMID:1983154), also on mice, described a reduction in pain responses, which were blocked by naloxone and yohimbine. Wagner’s team in 2024 (PMID:39728677) administered the vapor in short puffs, mimicking inhalation, and obtained an anxiolytic effect in females, while in males, it occurred only with a single puff.

These three studies have a boundary written more broadly. In humans, it has not been shown that myrcene alleviates insomnia at doses typical for inhalation of flower. The direction of the effect in rodents depends on the route of administration and sex: after intraperitoneal injection in 2002, a slightly anxiogenic effect was described, while after inhalation in 2024, an anxiolytic effect was observed in females. These two results do not cancel each other out; they only show that the conclusion depends on conditions that no popular strain database provides.

For the comparison of the two strains, this has one effect. The results of opposite signs come from different routes of administration and from animals of different sexes, and the name of the cultivar does not carry any of these conditions. Cataract Kush is listed in the catalog as an indica strain with a relaxing effect column, but this is based on the seller’s description, not any of the three cited studies.

How long does the effect last for each?

Equally long, as the course is determined by the route of administration, not the strain name. Neither for Beach Crasher nor for Cataract Kush has anyone measured the duration of effects separately, so any difference stated in commercial descriptions is a user report, not a measurement.

The route of administration determines the course more than the strain itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect wears off within two to four hours. After ingestion, the material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode lasts six, sometimes eight hours. Hence the most common mistake with oral administration: those who think nothing is happening after thirty minutes and take another dose will receive both doses at once. The above ranges describe the route of administration, not this strain; pharmacokinetic studies for a single cultivar have not been published.

This leads to a simple conclusion that organizes the entire comparison. Since the course depends on the route of administration, the two strains administered the same way differ at most in what the profile carries, and neither of their profiles has been confirmed by series analysis. Therefore, the question of which lasts longer does not have an answer based on data.

What adverse effects have been reported for each of these two strains?

Separately, nothing has been reported for either. Reports go to the registry under the product’s batch number, not under the cultivar name, so the difference in the number of descriptions for Beach Crasher and Cataract Kush would speak of the popularity of the entry, not its safety.

Reports of adverse effects are collected for the medicinal product with a batch number, not for the strain name, so the following concerns cannabis flower as a group of raw materials. The most commonly reported effects are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for cannabis flower in Poland do not separate them by individual products.

Both strains share the same trio of producers, so even if reports could be broken down by names, the difference between them would mix with the difference between batches. The only thing that can be said honestly is that the same description of the raw material group applies to both entries, and the discussion about symptoms is conducted with the attending physician, not with the strain description.

Why does the availability of both strains change over time?

Because there is no strain in the pharmacy, there is a registry entry of a specific producer. Each of these two names stands under four such entries, and at the time of gathering data for this comparison, two of them were listed as unavailable, so the picture changes without changing the name.

The distribution is asymmetrical in a way that is not visible from the name. For Beach Crasher, the available entries were S-LAB and Tilray, while the expired entries were S-LAB and Synoptis Pharma, meaning the same producer stood on both sides. For Cataract Kush, the available entries were S-LAB and Tilray, while the expired entries were Synoptis Pharma and Tilray. The current state of releases is maintained separately in an updated list of strains available in pharmacies, as the catalog ages faster than the text.

Finally, a note on naming, as two different shelves can be confused. The store category of flower on ubucha.pl is a different shelf than the pharmacy: it contains hemp flower with cannabidiol, sold without a prescription, without a common entry with the raw material described above. The full profiles of both cultivars are detailed separately, on the strain page Beach Crasher and on the strain page Cataract Kush.

Frequently Asked Questions

Are Beach Crasher and Cataract Kush the same strain family?

No, not in the sense that the breeder’s card understands family. Cataract Kush has OG Kush directly listed as a parent, while Beach Crasher leads to this line only through its second parent, TK Bx1. However, OG Kush is a name of a broad family in this comparison, not a single plant, so a common ancestor does not make these two strains siblings.

Which of these two strains is stronger?

Neither, if the question concerns the number on the label. Both have the same range of 16.2-24.2% in the registry, as both stand under several separate registry entries with two levels of declared potency. A specific packaged entry carries its own value, not the strain as a name.

Why are there no percentage shares of terpenes in this text?

Because the denominator of these shares is unknown. In the same database, the shares given for one entry of Beach Crasher sum to 86, for another entry of the same strain to exactly one hundred, and for Cataract Kush to 94. A number without a denominator looks in a text about a drug like a measurement, and it is not, so the composition stands here as a list of names.

Does myrcene help with sleep?

This has not been demonstrated in humans. A study from 2002 prolonged sleep induced by pentobarbital in mice, but after intraperitoneal injection and at doses not comparable to inhalation of flower. A study from 2024 administered vapor and measured anxiety, not sleep, and the result depended on the sex of the animals.

Does caryophyllene have analgesic effects in humans?

There is no data from studies in humans. Both studies referenced in this text were conducted on mice, with oral or systemic administration, not inhaled, and concerned inflammatory and neuropathic pain in animal models.

Where do the differences in descriptions of the same strain come from?

From the fact that the description comes from a catalog, not from the analysis of a single series. For Beach Crasher, two databases provide different sets of terpenes, and even one database describes two registry entries of the same cultivar differently. For Cataract Kush, there is one description, so contradictions are not visible, which does not mean that the composition has been confirmed.

This material is for informational purposes. Cannabis flower is a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category, and the method of treatment is determined by the attending physician. The editorial text was prepared by the editorial team of ubucha.pl.